DAWN has been in the news 857% more than usual
Mar 06, 2026, 5:34 PM
0.00%
What does DAWN do
Day One Biopharmaceuticals, based in Brisbane, California, focuses on developing cancer treatments, including its lead candidate tovorafenib. The company went public on May 27, 2021, and employs 174 people.
DAWN has been in the news recently: Day One Biopharmaceuticals, Inc. has been acquired by Servier for $21.50 per share in cash, totaling approximately $2.5 billion, which strengthens Servier's presence in pediatric glioma and broadens its oncology pipeline. In a broader market context, U.S. stocks experienced a decline, with the Dow Jones index falling about 500 points on the same day.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.